Elutia (ELUT) Cash from Investing Activities Growth (1y) (2020 - 2026)
Powered by 
Analysis
Elutia (ELUT) Cash from Investing Activities Growth (1y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.84 Bn | 174.23 Bn | 7.27 Bn | -15.64% |
| 2 | Intuitive Surgical | 128.02 Bn | 122.81 Bn | 1.96 Bn | -110.20% |
| 3 | Medtronic | 117.28 Bn | 108.46 Bn | 6.34 Bn | -125.17% |
| 4 | Stryker | 103.92 Bn | 100.44 Bn | 4.50 Bn | -514.42% |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | -73.71% |
| 6 | Edwards Lifesciences | 49.96 Bn | 45.70 Bn | 1.35 Bn | -12.26% |
| 7 | Alcon | 32.86 Bn | 31.40 Bn | 1.68 Bn | -44.16% |
| 8 | Dexcom | 32.25 Bn | 30.30 Bn | 830.00 Mn | 618.55% |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | 0.00% |
| 10 | Elutia | 34.94 Mn | 15.04 Mn | 1.45 Mn | 20.18% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.18% |
| Mar 31, 2026 | 87.77% |
| Dec 31, 2025 | 84,760.64% |
| Sep 30, 2025 | -15.17% |
| Jun 30, 2025 | -162.64% |
| Mar 31, 2025 | -1,753.33% |
| Dec 31, 2024 | -100.65% |
| Sep 30, 2024 | -782.26% |
| Jun 30, 2024 | 314.12% |
| Mar 31, 2024 | 91.76% |
| Dec 31, 2023 | 10,948.51% |
| Sep 30, 2023 | 47.01% |
| Jun 30, 2023 | 66.67% |
| Mar 31, 2023 | -435.29% |
| Dec 31, 2022 | -436.00% |
| Sep 30, 2022 | -20.62% |
| Jun 30, 2022 | -119.83% |
| Mar 31, 2022 | 74.05% |
| Dec 31, 2021 | 78.26% |
| Sep 30, 2021 | 77.75% |